These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H, Yamamoto K. Cancer; 1989 Jan 01; 63(1):126-32. PubMed ID: 2910410 [Abstract] [Full Text] [Related]
7. Clinical significance of genetic rearrangements in human neuroblastomas. Brodeur GM. Clin Chem; 1989 Jul 01; 35(7 Suppl):B38-42. PubMed ID: 2568197 [Abstract] [Full Text] [Related]
12. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. Kaneko Y, Kanda N, Maseki N, Nakachi K, Takeda T, Okabe I, Sakurai M. J Clin Oncol; 1990 Dec 01; 8(12):2005-13. PubMed ID: 2230892 [Abstract] [Full Text] [Related]
13. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM. J Clin Oncol; 1991 Apr 01; 9(4):581-91. PubMed ID: 2066755 [Abstract] [Full Text] [Related]
14. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM. Cancer Res; 1995 Oct 15; 55(20):4664-9. PubMed ID: 7553646 [Abstract] [Full Text] [Related]
16. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM. J Clin Oncol; 2000 May 15; 18(9):1888-99. PubMed ID: 10784629 [Abstract] [Full Text] [Related]
18. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Bourhis J, De Vathaire F, Wilson GD, Hartmann O, Terrier-Lacombe MJ, Boccon-Gibod L, McNally NJ, Lemerle J, Riou G, Bénard J. Cancer Res; 1991 Jan 01; 51(1):33-6. PubMed ID: 1988094 [Abstract] [Full Text] [Related]
20. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group. Christiansen H, Delattre O, Fuchs S, Theobald M, Christiansen NM, Berthold F, Lampert F. Prog Clin Biol Res; 1994 Jan 01; 385():19-25. PubMed ID: 7972212 [Abstract] [Full Text] [Related] Page: [Next] [New Search]